SURG vs STXS
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 15, 2026
SURG
STXS
Investment Advisor Scores
STXS
AI Analyst Insights
Detailed Metrics Comparison
| Metric | SURG | STXS | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 15.1515 | 19.6464 | SURG |
| PEG Ratio | 0.5333 | 1.3109 | SURG |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 40.7% | -12.8% | SURG |
| Earnings Growth | -77.7% | 0.0% | STXS |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 39.9/100 | 29.8/100 | SURG |
| Profit Margin | -47.9% | -74.2% | SURG |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | AVOID NEW MONEY | AVOID NEW MONEY | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
SURG
MarkdownPrice below a falling SMA50 (slope -22.7%), weak momentum, RSI 35
STXS
MarkdownPrice below a falling SMA50 (slope -7.3%), weak momentum, RSI 25
Fundamentals Snapshot
| Metric | SURG | STXS |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 12.7 | -6.8 |
| Trailing P/E | — | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.4% | -0.1% |
| Gross Margin | -0.2% | 0.6% |
| Operating Margin | 0.2% | -0.6% |
| EPS | -1.50 | -0.24 |
| Dividend Yield | — | — |